Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

an ace inhibitory peptide

A technology of inhibitory peptides and adjuvant therapy, applied in the field of ACE inhibitory peptides, can solve the problems of complex process, difficulty in obtaining high-purity peptides, and long time consumption, and achieve low cost effects

Active Publication Date: 2021-06-25
BOHAI UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, the traditional enzymatic hydrolysis-separation-purification method is mainly used to screen and identify ACE inhibitory peptides. This method is time-consuming, complicated and difficult to obtain high-purity peptides.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • an ace inhibitory peptide
  • an ace inhibitory peptide
  • an ace inhibitory peptide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Example 1 Simulated enzyme digestion and virtual screening of ovalbumin

[0018] 1. Virtual gastrointestinal enzymatic hydrolysis of ovalbumin.

[0019] Pepsin (EC 3.4.23.1), trypsin (EC 3.4.21.4) and chymotrypsin (EC 3.4.21.1) were selected to pass through the ExPASy PeptideCutter (http: / / web.expasy.org / peptide_cutter / ) with egg pairs. The albumin sequence (Accession of NCBI: 0705172A) was subjected to simulated digestion to obtain 104 peptide sequences. The tripeptide sequence was compared with the known ACE inhibitory peptides in the BIOPEP-UWM database (http: / / www.uwm.edu.pl / biochemia / index.php / en / biopep) to obtain 11 unreported tripeptide.

[0020] 2. Prediction of toxicity, water solubility and ADME properties.

[0021] Using the online tools ToxinPred (http: / / crdd.osdd.net / raghava / / toxinpred / ), peptide property calculator (http: / / www.innovagen.com / ) and admetSAR (http: / / lmmd.ecust.edu. cn / admetsarl / ) to predict the toxicity, solubility and ADME properties of ...

Embodiment 2 3

[0028] Example 2 Identification of Tripeptide CIK ACE Inhibitory Activity in Vitro

[0029] The ACE inhibitory activity of CIK was determined by HPLC. Take hippuryl-histidyl-leucine (HHL) substrate solution, add CIK solution and mix evenly, preheat in a constant temperature water bath at 37°C for 3-5 minutes, then add ACE solution and mix thoroughly, keep warm at 37°C for 30 minutes, 1mol / L HCl was added to terminate the reaction to obtain a reaction solution. At the same time, boric acid buffer solution was used instead of inhibitor solution as blank control group. The reaction solution was directly analyzed by HPLC system.

[0030] Chromatographic conditions: column temperature 25°C, flow rate 0.5mL / min, mobile phase acetonitrile / water 25:75 isocratic elution, detection wavelength 228nm.

[0031] The experimental results showed that the tripeptide CIK can effectively inhibit the activity of ACE, IC 50 The value was 161 μM.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides an angiotensin-converting enzyme (ACE) inhibitory peptide, the amino acid sequence of the ACE inhibitory peptide is Cys-Ile-Lys (CIK), the peptide can effectively inhibit ACE activity, and its IC 50 The value was 161 μM. The ACE inhibitory peptide involved in the present invention has the characteristics of small molecular weight, convenient artificial synthesis, strong activity, and high safety. The present invention provides a reference for the development of food, health care products and synthetic drugs for treating hypertension with ACE inhibitory function, and has a wide range of applications Prospects and very important significance.

Description

technical field [0001] The invention relates to the field of bioactive peptides, in particular to an ACE inhibitory peptide. Background technique [0002] Ovalbumin is the main protein component in egg whites, accounting for about 55% of the total protein. Ovalbumin is a good source of bioactive peptides. Many studies have focused on the enzymatic hydrolyzate of ovalbumin and its angiotensin-converting enzyme (ACE) inhibitory activity. [0003] ACE is a zinc-containing two-domain dipeptide carboxypeptidase that cleaves two amino acids at the C-terminus of angiotensin-I (ANG I) to generate angiotensin-II (ANG II) with pressor activity. Therefore, inhibiting the activity of ACE is an effective method to control hypertension. Clinically, synthetic drugs such as captopril, enalapril and lisinopril are usually used to treat hypertension. However, synthetic ACE inhibitor drugs usually have some side effects such as cough, hyperkalemia, rash, taste disturbance, headache and fat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/77C07K5/083
CPCC07K5/081C07K14/77
Inventor 于志鹏武思佳赵文竹慕一丹
Owner BOHAI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com